Health Tech
Cadence raises $100M Series C for AI-powered chronic disease management
Tags AI · Health Tech
Fierce Healthcare·
Health tech startup Cadence secured $100 million in Series C funding to advance its AI agents for chronic disease management, expanding in value-based care models and growing across new health systems.
Technical significance
AI agents for chronic disease management represent a shift from reactive to continuous care models. The $100M round signals investor confidence in AI-driven care coordination as a viable business model.